AbCellera Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ABCL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Mar 25	BuyUS$742,243	Carl Hansen	Individual	343,631	US$2.16
10 Mar 25	BuyUS$57,500	John Montalbano	Individual	25,000	US$2.30
06 Mar 25	BuyUS$140,568	John Montalbano	Individual	60,000	US$2.34
29 Aug 24	BuyUS$739,977	Carl Hansen	Individual	283,516	US$2.61

Insider Trading Volume

Insider Buying: ABCL insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABCL?
Owner Type	Number of Shares	Ownership Percentage
Hedge Funds	27,525,640	9.22%
Individual Insiders	68,557,415	23%
General Public	94,801,104	31.8%
Institutions	107,600,505	36%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.86% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.1%	Carl Hansen	57,041,640	US$122.1m	1.6%	no data
9.22%	Baker Bros. Advisors LP	27,525,640	US$58.9m	0%	0.45%
6.95%	UBS Asset Management AG	20,753,246	US$44.4m	221%	no data
4.48%	Capital Research and Management Company	13,361,096	US$28.6m	68.4%	no data
3.75%	Baillie Gifford & Co.	11,195,832	US$24.0m	-8.5%	0.01%
3.56%	Voya Investment Management LLC	10,624,185	US$22.7m	0%	0.02%
3.22%	Veronique Lecault	9,613,674	US$20.6m	0%	no data
1.5%	Allianz Global Investors U.S. LLC	4,490,520	US$9.6m	0%	0.07%
1.4%	OrbiMed Advisors LLC	4,180,768	US$8.9m	0%	0.13%
1.38%	ArrowMark Colorado Holdings, LLC	4,105,095	US$8.8m	0%	0.13%
1.2%	BlackRock, Inc.	3,576,208	US$7.7m	-12.7%	no data
1.05%	Two Sigma Investments, LP	3,126,789	US$6.7m	-4.01%	0.01%
0.97%	Renaissance Technologies LLC	2,894,029	US$6.2m	16.4%	0.01%
0.94%	Prosight Management, LP	2,815,652	US$6.0m	-61.7%	1.83%
0.89%	Two Sigma Advisers, LP	2,644,800	US$5.7m	1.4%	0.01%
0.87%	Tang Capital Management, LLC	2,600,000	US$5.6m	0.67%	0.27%
0.61%	Citadel Advisors LLC	1,814,474	US$3.9m	204%	no data
0.6%	Guardian Capital Advisors LP	1,786,414	US$3.8m	0%	0.36%
0.6%	Guardian Partners Inc.	1,786,414	US$3.8m	0%	0.34%
0.53%	LGPS Central Limited	1,570,535	US$3.4m	0%	0.02%
0.48%	Michael Hayden	1,441,642	US$3.1m	0%	no data
0.43%	Norges Bank Investment Management	1,284,533	US$2.7m	0%	no data
0.41%	Morgan Stanley, Investment Banking and Brokerage Investments	1,226,784	US$2.6m	43.6%	no data
0.38%	Novo Holdings A/S	1,126,915	US$2.4m	0%	no data
0.34%	Acatis Anlageberatung fur Investmentfonds GmbH	1,002,300	US$2.1m	0%	0.14%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/06/03 03:29
End of Day Share Price	2025/06/03 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AbCellera Biologics Inc. is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Robert Wasserman	Benchmark Company
Antonia Borovina	Bloom Burton & Co.
David Martin	Bloom Burton & Co.